Blood Transfusion Diagnostics Market

Blood Transfusion Diagnostics Market (Product Type: Instruments and Kits & Reagents; and Application: Blood Grouping and Disease Screening) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031

Blood Transfusion Diagnostics Market Outlook 2031

  • The global industry was valued at US$ 4.3 Bn in 2022
  • It is estimated to grow at a CAGR of 5.0% from 2023 to 2031 and reach US$ 6.6 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of blood-related chronic diseases is fueling the blood transfusion diagnostics market size. Sickle cell anemia and leukemia require blood and blood component transfusion and diagnostics products for long-term patient care. Analyzers, centrifuges, and kits & reagents are gaining traction for blood screening, grouping, and testing.

Prominent players operating in the global blood transfusion diagnostics industry are investing in the R&D of new products to expand their product portfolio. They are also adopting automation to optimize blood collection processes. Introduction of advanced transfusion techniques is likely to offer lucrative blood transfusion diagnostics market opportunities to vendors.

Blood Transfusion Diagnostics Market

Market Introduction

Blood transfusion is a medical procedure in which blood is intravenously transferred between a donor and a patient. The procedure is minimally intrusive and usually occurs without any complication in 2-4 hours. Blood transfusion diagnostics are products applied to conduct tests before the transfusion of blood. These products include instruments such as analyzers, centrifuges, and kits & reagents for blood grouping and screening activities. Blood screening reagents and kits are used in the red blood cell determination of the ABO blood group. Blood donor screening is conducted before transfusion for certain additional proteins (antibodies) that may cause adverse reactions in a person receiving the transfusion.

People aged 65 years and over often require blood transfusion, especially those suffering from anemia. Children in developing countries are usually susceptible to malaria, anemia, and trauma-related injuries and may require blood transfusion for effective treatment.

Rise in Prevalence of Blood-related Diseases Fueling Blood Transfusion Diagnostics Market Development

Chronic diseases such as aplastic anemia, sickle cell anemia, hemophilia, and leukemia require blood or blood component transfusion. A significant increase in the global geriatric population, sedentary lifestyles, and surge in pollution are some of the major factors propelling the prevalence of blood-related chronic diseases.

According to the World Health Organization, over 118.5 million units of blood is donated and collected annually. However, there is a growing need for transfusions due to a rise in the prevalence of blood-related diseases worldwide. This, in turn, is projected to spur the blood transfusion diagnostics market growth in the near future.

According to a report by the National Sickle Cell Anaemia Elimination Mission, around 140,000 people in India suffer from sickle cell anemia. As per the reports by the Canadian Hemophilia Society, published in February 2022, around 3,100 people in Canada suffered from Hemophilia A and B. Hence, increase in prevalence of blood-related chronic diseases is driving the blood transfusion diagnostics market revenue.

High Demand for Blood Donations

Government and private organizations are focused on boosting awareness regarding blood donation. In October 2022, National Health Service (NHS) Blood and Transplant started a blood donation campaign to combat sickle cell anemia and improve the number of blood donors for the disease. Private employers are also encouraging their workers to donate blood. These initiatives are propelling the blood transfusion diagnostics market progress. Automation is gaining traction in blood collection facilities. It helps reduce the time required for blood tests, thereby accelerating the blood transfusion process. Governments in various countries are implementing stringent blood testing regulations. This is prompting vendors to develop standard blood transfusion diagnostic products and solutions that adhere to these regulations.

Regional Outlook

According to the latest blood transfusion diagnostics market analysis, North America held largest share in 2022. Presence of several active blood donors and increase in number of blood transfusions are fueling the market dynamics of the region. The U.S. and Canada are major markets for blood transfusion diagnostics due to the implementation of stringent blood test safety policies.

As per the latest blood transfusion diagnostics market forecast, the industry in Asia Pacific is expected to grow at a steady pace during the forecast period. Rise in geriatric population and growth in cases of blood-related disorders are driving the market landscape in the region. China and India are major markets for blood transfusion diagnostics owing to the presence of a large patient pool requiring blood transfusions and growth in awareness regarding infectious diseases.

Analysis of Key Players

According to recent blood transfusion diagnostics market trends, prominent manufacturers are investing heavily in the development of advanced blood typing diagnostics. Close collaborations within the industry along with mergers and acquisitions are seen as key strategies to build a better product portfolio and maintain a strong stand in the sector. In March 2021, Bio-Rad Laboratories, Inc. entered a global partnership with F. Hoffmann-La Roche AG to offer customers a range of bar-coded, load-and-go quality control tubes that enhance workflow productivity and efficiency.

BAG Health Care GmbH, Abbott, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, DiaSorin S.p.A., Grifols, S.A., Werfen, Hologic, Inc., Ortho Clinical Diagnostics, and Alive Dx are key companies operating in this market.

These companies have been profiled in the blood transfusion diagnostics market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.

Key Developments

  • In November 2023, Grifols launched its new Grifols sCD38 solution, a soluble recombinant protein designed to block anti-CD38 antibodies in multiple myeloma patients receiving daratumumab therapy. The protein ensures quick and accurate blood transfusion tests that are critical for proper treatment.
  • In March 2023, Werfen completed the acquisition of Immucor, Inc., a privately held, US-based company, in the in vitro diagnostics sector

Blood Transfusion Diagnostics Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 4.3 Bn
Market Forecast Value in 2031 US$ 6.6 Bn
Growth Rate (CAGR) 5.0%
Forecast Period 2023-2031
Historical Data Available for 2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia and CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Market Segmentation
  • Product Type
    • Instruments
    • Kits & Reagents
  • Application
    • Blood Grouping
    • Disease Screening
      • Molecular Disease Screening
      • Serological Disease Screening
  • End-user
    • Hospitals
    • Diagnostics Laboratories
    • Blood Banks
    • Plasma Fractionation Companies
    • Others
Companies Profiled
  • BAG Health Care GmbH
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • DiaSorin S.p.A.
  • Grifols, S.A.
  • Werfen
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • Alive Dx
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global blood transfusion diagnostics market in 2022?

It was valued at US$ 4.3 Bn in 2022

How is the blood transfusion diagnostics business expected to grow by 2031?

It is projected to grow at a CAGR of 5.0% from 2023 to 2031

What are the key factors driving the demand for blood transfusion diagnostics?

Rise in prevalence of blood-related diseases and high demand for blood donations

Which blood transfusion diagnostics product type segment held the largest share in 2022?

The kits & reagents product type segment held the largest share in 2022

Which was the major region in the global blood transfusion diagnostics industry in 2022?

North America dominated the global landscape in 2022

Who are the key blood transfusion diagnostics manufacturers?

BAG Health Care GmbH, Abbott, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, DiaSorin S.p.A., Grifols, S.A., Werfen, Hologic, Inc., Ortho Clinical Diagnostics, and Alive Dx

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Blood Transfusion Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Instruments

            6.3.2. Kits & Reagents

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Blood Grouping

            7.3.2. Disease Screening

                7.3.2.1. Molecular Disease Screening

                7.3.2.2. Serological Disease Screening

        7.4. Market Attractiveness Analysis, by Application

    8. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Diagnostics Laboratories

            8.3.3. Blood Banks

            8.3.4. Plasma Fractionation Companies

            8.3.5. Others

        8.4. Market Attractiveness Analysis, by Application

    9. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Blood Transfusion Diagnostics Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product Type, 2017–2031

            10.3.1. Instruments

            10.3.2. Kits & Reagents

        10.4. Market Value Forecast, by Application, 2017–2031

            10.4.1. Blood Grouping

            10.4.2. Disease Screening

                10.4.2.1. Molecular Disease Screening

                10.4.2.2. Serological Disease Screening

        10.5. Market Value Forecast, by End-user, 2017–2031

            10.5.1. Hospitals

            10.5.2. Diagnostics Laboratories

            10.5.3. Blood Banks

            10.5.4. Plasma Fractionation Companies

            10.5.5. Others

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Product Type

            10.7.2. By Application

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product Type, 2017–2031

            11.3.1. Instruments

            11.3.2. Kits & Reagents

        11.4. Market Value Forecast, by Application, 2017–2031

            11.4.1. Blood Grouping

            11.4.2. Disease Screening

                11.4.2.1. Molecular Disease Screening

                11.4.2.2. Serological Disease Screening

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Diagnostics Laboratories

            11.5.3. Blood Banks

            11.5.4. Plasma Fractionation Companies

            11.5.5. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Product Type

            11.7.2. By Application

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product Type, 2017–2031

            12.3.1. Instruments

            12.3.2. Kits & Reagents

        12.4. Market Value Forecast, by Application, 2017–2031

            12.4.1. Blood Grouping

            12.4.2. Disease Screening

                12.4.2.1. Molecular Disease Screening

                12.4.2.2. Serological Disease Screening

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Diagnostics Laboratories

            12.5.3. Blood Banks

            12.5.4. Plasma Fractionation Companies

            12.5.5. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Product Type

            12.7.2. By Application

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product Type, 2017–2031

            13.3.1. Instruments

            13.3.2. Kits & Reagents

        13.4. Market Value Forecast, by Application, 2017–2031

            13.4.1. Blood Grouping

            13.4.2. Disease Screening

                13.4.2.1. Molecular Disease Screening

                13.4.2.2. Serological Disease Screening

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Diagnostics Laboratories

            13.5.3. Blood Banks

            13.5.4. Plasma Fractionation Companies

            13.5.5. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Product Type

            13.7.2. By Application

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Product Type, 2017–2031

            14.3.1. Instruments

            14.3.2. Kits & Reagents

        14.4. Market Value Forecast, by Application, 2017–2031

            14.4.1. Blood Grouping

            14.4.2. Disease Screening

                14.4.2.1. Molecular Disease Screening

                14.4.2.2. Serological Disease Screening

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Diagnostics Laboratories

            14.5.3. Blood Banks

            14.5.4. Plasma Fractionation Companies

            14.5.5. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Product Type

            14.7.2. By Application

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Grifols, S.A.

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Werfen

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Ortho Clinical Diagnostics

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Abbott

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Bio-Rad Laboratories, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. F. Hoffmann-La Roche AG

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Alive Dx

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. BAG Health Care GmbH

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. DiaSorin S.p.A.

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

            15.3.10. Hologic, Inc.

                15.3.10.1. Company Overview

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Financial Overview

                15.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 07: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 15: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Blood Transfusion Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

    Figure 02: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn), by Product Type, 2022

    Figure 03: Global Blood Transfusion Diagnostics Market Value Share, by Product Type, 2022

    Figure 04: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn), by Application, 2022

    Figure 05: Global Blood Transfusion Diagnostics Market Value Share, by Application, 2022

    Figure 06: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2022

    Figure 08: Global Blood Transfusion Diagnostics Market Value Share, by Region, 2022

    Figure 09: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 11: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 12: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 13: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 14: Global Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 15: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 16: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Region, 2022 and 2031

    Figure 17: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Region, 2022-2031

    Figure 18: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Country, 2022 and 2031

    Figure 21: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 22: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 23: North America Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 24: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 25: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 26: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 31: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 32: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 33: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 34: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 35: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 40: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 41: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 42: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 43: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 44: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 49: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 50: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 51: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 52: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 53: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 57: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 58: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 59: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 60: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 61: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 62: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved